Literature DB >> 9852287

A novel nuclear substructure, ND10: distribution in normal and neoplastic human tissues.

Y Cho1, I Lee, G G Maul, E Yu.   

Abstract

ND10 are recently characterized nuclear domains that are composed of 0.5 microm sized, precisely circumscribed dots in cultured human cell lines. To investigate the distribution and number of ND10 on various types of normal and neoplastic human tissues, we carried out immunostaining and immunoprecipitation analyses with monoclonal antibodies 138 and 1150. The number of ND10 varied from 1 to 10 or more in various tissues as did their size. ND10 were diffusely located in early embryonic and normal tissues, except for the exocrine and endocrine cells of the pancreas and for hepatocytes. In normal squamous mucosa, basal cells had more ND10 than did differentiated superficial squamous cells. The number and size of ND10 were markedly increased in malignant neoplasms but were similar in benign tumors and corresponding normal tissues. Sex hormone-related normal tissues, such as the endometrium or myometrium, and neoplasms strongly stained for ND10. The distribution pattern of ND10 in human tissues indicates that they are conserved nuclear substructures that are closely associated with cellular differentiation, hormonal stimulation, and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852287     DOI: 10.3892/ijmm.1.4.717

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  10 in total

1.  Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture.

Authors:  X p Chen; J Li; M Mata; J Goss; D Wolfe; J C Glorioso; D J Fink
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  N-terminal phosphorylation sites of herpes simplex virus 1 ICP0 differentially regulate its activities and enhance viral replication.

Authors:  Heba H Mostafa; Thornton W Thompson; David J Davido
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

3.  TRIM proteins and cancer.

Authors:  Shigetsugu Hatakeyama
Journal:  Nat Rev Cancer       Date:  2011-10-07       Impact factor: 60.716

4.  Expression of promyelocytic leukemia protein increases during the differentiation of human neuroblastoma cells.

Authors:  Eunsil Yu; Eun Kyung Choi; Chong Jai Kim
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

5.  Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; B N Carriere; R L Hendricks
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.

Authors:  Kazuyuki Kuwayama; Kazuhito Matsuzaki; Yoshihumi Mizobuchi; Hideo Mure; Keiko T Kitazato; Teruyoshi Kageji; Mitsuyoshi Nakao; Shinji Nagahiro
Journal:  Neuro Oncol       Date:  2008-09-23       Impact factor: 12.300

7.  Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.

Authors:  Li Wang; Stefan L Oliver; Marvin Sommer; Jaya Rajamani; Mike Reichelt; Ann M Arvin
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

8.  PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.

Authors:  A M Ishov; A G Sotnikov; D Negorev; O V Vladimirova; N Neff; T Kamitani; E T Yeh; J F Strauss; G G Maul
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

9.  PML promotes MHC class II gene expression by stabilizing the class II transactivator.

Authors:  Tobias Ulbricht; Mohammad Alzrigat; Almut Horch; Nina Reuter; Anna von Mikecz; Viktor Steimle; Eberhard Schmitt; Oliver H Krämer; Thomas Stamminger; Peter Hemmerich
Journal:  J Cell Biol       Date:  2012-09-24       Impact factor: 10.539

Review 10.  Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.

Authors:  Erin L Reineke; Hung-Ying Kao
Journal:  Int J Biol Sci       Date:  2009-05-22       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.